Nine Masts Capital
THC icon

Nine Masts Capital’s Tenet Healthcare THC Stock Holding History

Nine Masts Capital’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$337K Buy
+1,319
New +$325K 0.04% 150

Other funds holding THC

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Nine Masts Capital's THC Position: Q3 2026 in Review

Nine Masts Capital opened a new position in Tenet Healthcare (THC) in Q3 2026: 1,319 shares worth $337K. The stake represents 0.04% of the portfolio and ranks #150 among its holdings.

635 funds tracked by Wall St. Rank hold THC as of Q3 2026.

  • Nine Masts Capital held 1,319 shares of Tenet Healthcare worth $337K as of Q3 2026.
  • Tenet Healthcare was a new Nine Masts Capital position in Q3 2026.
  • Tenet Healthcare made up 0.04% of Nine Masts Capital's portfolio in Q3 2026, its #150 holding.
  • 635 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2026.

Based on Nine Masts Capital's 13F filing for Q3 2026, filed 9 Nov 2026.